The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of pima indians
Open accessAbstract
BACKGROUND: The relative roles of obesity, insulin resistance, insulin secretory dysfunction, and excess hepatic glucose production in the development of non-insulin-dependent diabetes mellitus (NIDDM) are controversial. We conducted a prospective study to determine which of these factors predicted the development of the disease in a group of Pima Indians. METHODS: A body-composition assessment, oral and intravenous glucose-tolerance tests, and a hyperinsulinemic--euglycemic clamp study were performed in 200 non-diabetic Pima Indians (87 women and 113 men; mean [+/- SD] age, 26 +/- 6 years). The subjects were followed yearly thereafter for an average of 5.3 years. RESULTS: Diabetes developed in 38 subjects during follow-up. Obesity, insulin resistance (independent of obesity), and low acute plasma insulin response to intravenous glucose (with the degree of obesity and insulin resistance taken into account) were predictors of NIDDM: The six-year cumulative incidence of NIDDM was 39 percent in persons with values below the median for both insulin action and acute insulin response, 27 percent in those with values below the median for insulin action but above that for acute insulin response, 13 percent in those with values above the median for insulin action and below that for acute insulin response, and 0 in those with values originally above the median for both characteristics. CONCLUSIONS: Insulin resistance is a major risk factor for the development of NIDDM: A low acute insulin response to glucose is an additional but weaker risk factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance and concurrent relative insulin deficiency and glucagon dysregulation underlie T2D pathophysiology.33–35”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, progressive β-cell failure is required and ultimately responsible for type 2 diabetes to become fully manifest ( 1 , 34 , 35 , 37 , 38 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“Thus, re-examination of data from some other studies of high risk subjects with NGT would suggest that the conclusions in those papers disputing the presence of beta-cell dysfunction are erroneous because no difference in the insulin responses existed between groups despite the presence of insulin resistance, indicating impaired beta-cell adaptation [108, 109, 110, 111, 112, 113, 114].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. D. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,680
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158
Ohlson, L., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,143
Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
Vionnet, N., Stoffel, M., Takeda, J., Yasuda, K., Bell, G. I., Zouali, H., Lesage, S., Velho, G., Iris, F., Passa, P., et al. (1992) · Nature · doi:10.1038/356721a0 · Cited by 604
Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
Knowler, W. C., Pettitt, D. J., Saad, M. F., & Bennett, P. H. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060101 · Cited by 578
Self-citationImpaired Glucose Tolerance as a Disorder of Insulin Action
Lillioja, S., Mott, D. M., Howard, B. V., Bennett, P. H., Yki-Järvinen, H., Freymond, D., Nyomba, B. L., Zurlo, F., Swinburn, B., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181901 · Cited by 578
Self-citationBogardus, C., Lillioja, S., Howard, B. V., Reaven, G. M., & Mott, D. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111533 · Cited by 397
Self-citation
Research works printed but not linked: 2
- 1985, World Health Organ Tech Rep Ser, 727, 9
- Gottesman I, 1983, Am J Physiol, 244, E632
Cited by
Sorted by citations
Items 101–200 of 1,003
Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements
Stern, S. E., Williams, K., Ferrannini, E., DeFronzo, R. A., Bogardus, C., & Stern, M. P. (2005) · Diabetes · doi:10.2337/diabetes.54.2.333 · Cited by 384
Self-citationSchulze, M. B., Hoffmann, K., Boeing, H., Linseisen, J., Rohrmann, S., Möhlig, M., Pfeiffer, A. F. H., Spranger, J., Thamer, C., Häring, H., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2089 · Cited by 382
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction
Ræder, H., Johansson, S., Holm, P. I., Haldorsen, I. S., Mas, E., Sbarra, V., Nermoen, I., Eide, S. Å., Grevle, L., Bjørkhaug, L., et al. (2005) · Nature Genetics · doi:10.1038/ng1708 · Cited by 379
Lee, D. H., Lee, I. K., Porta, M. S., Steffes, M. W., & Jacobs, D. R. (2007) · Diabetologia · doi:10.1007/s00125-007-0755-4 · Cited by 374
Baier, L. J., Sacchettini, J. C., Knowler, W. C., Eads, J. C., Paolisso, G., Tataranni, P. A., Mochizuki, H., Bennett, P. H., Bogardus, C., & Procházka, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117778 · Cited by 371
Self-citationFunctional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369
Paolisso, G., Tataranni, P. A., Foley, J. E., BOGARDUS, C., Howard, B. V., & Ravussin, É. (1995) · Diabetologia · doi:10.1007/bf00422371 · Cited by 369
Self-citationShah, P., Vella, A., Basu, A., Basu, R., Schwenk, W. F., & Rizza, R. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6993 · Cited by 368
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
Solomon, C. G. (2001) · JAMA · doi:10.1001/jama.286.19.2421 · Cited by 362
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362
Lyssenko, V., Almgren, P., Anevski, D., Perfekt, R., Lahti, K., Nissén, M., Isomaa, B., Forsen, B., Homström, N., Saloranta, C., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.1.166 · Cited by 362
Weyer, C., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.89 · Cited by 358
Self-citationTripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M., Tuomi, T., & Groop, L. (2000) · Diabetes · doi:10.2337/diabetes.49.6.975 · Cited by 358
An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods
Holt, S., Miller, J., & Petocz, P. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.5.1264 · Cited by 353
Exercise or exercise and diet for preventing type 2 diabetes mellitus
Orozco, L. J., Buchleitner, A. M., Giménez‐Pérez, G., Figuls, M. R. I., Richter, B., & Mauricio, D. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub3 · Cited by 346
Kiechl, S. J., Willeit, J., Poewe, W. H., Egger, G., Oberhollenzer, F., Muggeo, M., & Bonora, E. (1996) · BMJ · doi:10.1136/bmj.313.7064.1040 · Cited by 344
The Cells of the Islets of Langerhans
Xavier, G. D. S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030054 · Cited by 343
Physical activity and diabetes prevention
LaMonte, M. J., Blair, S. N., & Church, T. S. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00193.2005 · Cited by 340
Buchanan, T. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7339 · Cited by 339
Meigs, J. B., Muller, D. C., Nathan, D. M., Blake, D. R., & Andres, R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1475 · Cited by 339
Epigallocatechin Gallate Supplementation Alleviates Diabetes in Rodents
Wolfram, S., Raederstorff, D., Preller, M., Wang, Y., Teixeira, S. R., Riegger, C., & Weber, P. (2006) · Journal of Nutrition · doi:10.1093/jn/136.10.2512 · Cited by 333
A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men
Ma, J., Giovannucci, E. L., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J. M., & Stampfer, M. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh082 · Cited by 331
Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus
Schwartz, S. L., Raskin, P., Fonseca, V. A., & Graveline, J. F. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381302 · Cited by 328
Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
DeFronzo, R. A., Eldor, R., & Abdul‐Ghani, M. A. (2013) · Diabetes Care · doi:10.2337/dcs13-2011 · Cited by 323
Association between triglyceride glucose index and arterial stiffness in Korean adults
Lee, S. B., Ahn, C. W., Lee, B. K., Kang, S., Nam, J. S., You, J. H., Kim, M. J., Kim, M. K., & Park, J. S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0692-1 · Cited by 315
Metformin for the treatment of the polycystic ovary syndrome
Nestler, J. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0707092 · Cited by 313
Cheal, K. L., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Ford, E. S. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1195 · Cited by 312
Petersen, K. F., Dufour, S., & Shulman, G. I. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020233 · Cited by 308
Metabolic Signatures of Insulin Resistance in 7,098 Young Adults
Würtz, P., Mäkinen, V., Soininen, P., Kangas, A. J., Tukiainen, T., Kettunen, J., Savolainen, M. J., Tammelin, T., Viikari, J. S. A., Rönnemaa, T., et al. (2012) · Diabetes · doi:10.2337/db11-1355 · Cited by 308
Lee, D., Lee, I., Jin, S.-H., Steffes, M. W., & Jacobs, D. R. (2007) · Diabetes Care · doi:10.2337/dc06-2190 · Cited by 306
Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders
Song, R., Peng, W., Zhang, Y., Lv, F., Wu, H., Guo, J., Cao, Y., Pi, Y., Zhang, X., Li, J., et al. (2013) · Nature · doi:10.1038/nature11834 · Cited by 305
Skeletal muscle membrane lipid composition is related to adiposity and insulin action.
Pan, D. A., Lillioja, S., Milner, M. R., Kriketos, A. D., Baur, L. A., Bogardus, C., & Storlien, L. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118350 · Cited by 304
Self-citationThe evolution of β‐cell dysfunction and insulin resistance in type 2 diabetes
Bergman, R. N., Finegood, D. T., & Kahn, S. E. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.5.x · Cited by 302
The metabolic syndrome in children and adolescents
Cruz, M. L., & Goran, M. I. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0012-x · Cited by 302
Link between obesity and type 2 diabetes
Golay, A., & Ybarra, J. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.010 · Cited by 301
Consequences of Fetal Exposure to Maternal Diabetes in Offspring
Fetita, L.-S., Sobngwi, E., Serradas, P., Calvo, F., & Gautier, J.-F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0624 · Cited by 299
Florez, J. C. (2008) · Diabetologia · doi:10.1007/s00125-008-1025-9 · Cited by 299
Weyer, C., Hanson, R. L., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2094 · Cited by 297
Self-citationThe Central Melanocortin System Can Directly Regulate Serum Insulin Levels*
Fan, W., Dinulescu, D. M., Butler, A. A., Zhou, J., Marks, D. L., & Cone, R. D. (2000) · Endocrinology · doi:10.1210/endo.141.9.7665 · Cited by 294
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
Leo, V. D., Marca, A. L., & Petraglia, F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0015 · Cited by 291
Effect of a diabetic environment in utero on predisposition to type 2 diabetes
Sobngwi, E., Boudou, P., Mauvais‐Jarvis, F., Leblanc, H., Velho, G., Vexiau, P., Porcher, R., Hadjadj, S., Pratley, R. E., Tataranni, P. A., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13505-2 · Cited by 290
Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM?
Taylor, S. I., Accili, D., & Imai, Y. (1994) · Diabetes · doi:10.2337/diab.43.6.735 · Cited by 289
Mechanisms of Insulin Resistance in Humans and Possible Links With Inflammation
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2005) · Hypertension · doi:10.1161/01.hyp.0000163475.04421.e4 · Cited by 289
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
Baier, L. J., Permana, P. A., Yang, X., Pratley, R. E., Hanson, R. L., Shen, G.-Q., Mott, D. M., Knowler, W. C., Cox, N. J., Horikawa, Y., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10665 · Cited by 286
Self-citationHyperinsulinemia: An Early Indicator of Metabolic Dysfunction
Thomas, D. D., Corkey, B. E., Istfan, N. W., & Apovian, C. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00065 · Cited by 284
Choi, C. S., Befroy, D. E., Codella, R., Kim, S., Reznick, R. M., Hwang, Y.-J., Liu, Z.-X., Lee, H.-Y., Distefano, A., Samuel, V. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810339105 · Cited by 279
Central insulin action regulates peripheral glucose and fat metabolism in mice
Koch, L., Wunderlich, F. T., Seibler, J., Könner, A. C., Hampel, B., Irlenbusch, S., Brabant, G. E., Kahn, C. R., Schwenk, F., & Brüning, J. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31073 · Cited by 278
Peters, R. K., Xiang, A., Kjos, S. L., & Buchanan, T. A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90405-5 · Cited by 273
Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals
Bonora, E., Kiechl, S. J., Willeit, J., Oberhollenzer, F., Egger, G., Meigs, J. B., Bonadonna, R. C., & Muggeo, M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1782 · Cited by 272
Insulin resistance, inflammation, and the prediabetic state
Haffner, S. M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00612-x · Cited by 270
McLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., & Reaven, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.032 · Cited by 268
Hani, E. H., Boutin, P., Durand, E., Inoue, H., Permutt, M. A., Velho, G., & Froguel, P. (1998) · Diabetologia · doi:10.1007/s001250051098 · Cited by 268
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
Ferrannini, E., & DeFronzo, R. A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv239 · Cited by 265
Clausen, J. O., Borch-Johnsen, K., Ibsen, H., Bergman, R. N., Hougaard, P., Winther, K., & Pedersen, O. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118903 · Cited by 259
Perseghin, G., Caumo, A., Caloni, M., Testolin, G., & Luzi, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7902 · Cited by 259
Obesity and Insulin Resistance
Després, J., & Marette, A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_4 · Cited by 254
Serum Vitamin D Levels and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
He, C., Lin, Z., Robb, S., & Ezeamama, A. (2015) · Nutrients · doi:10.3390/nu7064555 · Cited by 242
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 242
Relatively low plasma leptin concentrations precede weight gain in Pima Indians
Ravussin, É., Pratley, R. E., Maffei, M., Wang, H., Friedman, J. M., Bennett, P. H., & Bogardus, C. (1997) · Nature Medicine · doi:10.1038/nm0297-238 · Cited by 240
Self-citationGoran, M. I., Bergman, R. N., Ávila, Q., Watkins, M. P., Ball, G. D. C., Shaibi, G. Q., Weigensberg, M. J., & Cruz, M. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031402 · Cited by 236
Liu, S. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719227 · Cited by 235
Festa, A., Hanley, A. J., Tracy, R. P., D’Agostino, R., & Haffner, S. M. (2003) · Circulation · doi:10.1161/01.cir.0000091339.70120.53 · Cited by 235
Role of adiponectin in human skeletal muscle bioenergetics
Civitarese, A. E., Ukropcova, B., Carling, S., Hulver, M., DeFronzo, R. A., Mandarino, L., Ravussin, E., & Smith, S. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.002 · Cited by 234
Williams, J. T., Eerdewegh, P. V., Almasy, L. A., & Blangero, J. (1999) · The American Journal of Human Genetics · doi:10.1086/302570 · Cited by 234
Meier, J. J., Hücking, K., Holst, J. J., Deacon, C. F., Schmiegel, W., & Nauck, M. A. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2497 · Cited by 233
Insulin Resistance: Cellular and Clinical Concepts
Cefalu, W. T. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122600103 · Cited by 232
Metabolic Changes in Persons After Spinal Cord Injury
Bauman, W. A., & Spungen, A. M. (2000) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(18)30150-5 · Cited by 231
Insulin resistance and coronary heart disease in nondiabetic individuals
Reaven, G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241885 · Cited by 227
Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart Disease
Haffner, S. M., & Miettinen, H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00027-2 · Cited by 227
Haber, C. A., Lam, T. K. T., Yu, Z., Gupta, N., Goh, T. T., Bogdanovic, E., Giacca, A., & Fantus, I. G. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00355.2002 · Cited by 226
Tamariz, L. J., Young, J. H., Pankow, J. S., Yeh, H., Schmidt, M. I., Astor, B. C., & Brancati, F. L. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn243 · Cited by 224
Legro, R. S., Bentley–Lewis, R., Driscoll, D. A., Wang, S. C., & Dunaif, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8513 · Cited by 223
Gerich, J. E. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.4.447 · Cited by 222
Adiposity, Type 2 Diabetes, and Alzheimer's Disease
Luchsinger, J. A., & Gustafson, D. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1022 · Cited by 221
Nongenetic mouse models of non—insulin-dependent diabetes mellitus
Luo, J., Quan, J., Tsai, J., Hobensack, C. K., Sullivan, C., Hector, R., & Reaven, G. M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90027-0 · Cited by 221
Yialamas, M. A., Dwyer, A. A., Hanley, E., Lee, H., Pitteloud, N., & Hayes, F. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0454 · Cited by 220
Sleep Duration as a Risk Factor for Incident Type 2 Diabetes in a Multiethnic Cohort
Beihl, D. A., Liese, A. D., & Haffner, S. M. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2008.12.001 · Cited by 219
The fourth Musketeer ? from Alexandre Dumas to Claude Bernard
Reaven, G. M. (1995) · Diabetologia · doi:10.1007/s001250050247 · Cited by 219
The metabolic syndrome: time to get off the merry-go-round?: Review: The metabolic syndrome
Reaven, G. M. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02325.x · Cited by 214
Obstructive Sleep Apnea–Dependent and –Independent Adrenergic Activation in Obesity
Grassi, G. M., Facchini, A., Trevano, F. Q., Dell’Oro, R., Arenare, F., Tana, F., Bolla, G. B., Monzani, A., Robuschi, M., & Mancia, G. (2005) · Hypertension · doi:10.1161/01.hyp.0000174243.39897.6c · Cited by 214
GENETICS OF NON-INSULIN-DEPENDENT (TYPE-II) DIABETES MELLITUS
Kahn, C. R., Vicent, D., & Doria, A. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.509 · Cited by 213
Clausen, J. O., Hansen, T. F., Bjørbæk, C., Echwald, S. M., Urhammer, S. A., Rasmussen, S. S., Andersen, C., Hansen, L., Almind, K., Pedersen, O. B., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92779-4 · Cited by 213
Review of methods for detecting glycemic disorders
Bergman, M., Abdul‐Ghani, M. A., DeFronzo, R. A., Manco, M., Sesti, G., Fiorentino, T. V., Ceriello, A., Rhee, M. K., Phillips, L. S., Chung, S. T., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108233 · Cited by 210
Pathophysiology of Chronic Left Ventricular Dysfunction
Marinho, N. V. S., Keogh, B. E., Costa, D. C., Lammertsma, A. A., Ell, P. J., & Camici, P. G. (1996) · Circulation · doi:10.1161/01.cir.93.4.737 · Cited by 210
Phenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208
Zavaroni, I., Bonini, L., Gasparini, P., Barilli, A. L., Zuccarelli, A., Dall’Aglio, E., Delsignore, R., & Reaven, G. M. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90195-6 · Cited by 207
Vaag, A., Henriksen, J. E., Madsbad, S., Holm, N., & Beck-Nielsen, H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117715 · Cited by 206
Tripathy, D., Almgren, P., Tuomi, T., & Groop, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2204 · Cited by 206
An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians.
Pratley, R. E., Thompson, D. B., Procházka, M., Baier, L. J., Mott, D. M., Ravussin, É., Sakul, H., Ehm, M. G., Burns, D. K., Foroud, T., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1850 · Cited by 206
Self-citationLebovitz, H. E. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1339 · Cited by 205
Mittelman, S. D., Citters, G. W. V., Kim, S. P., Davis, D. A., Dea, M. K., Hamilton-Wessler, M., & Bergman, R. N. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2116 · Cited by 205
McLaughlin, T. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.7.642 · Cited by 202
Adipose Tissue Metabolites and Insulin Resistance in Nondiabetic Asian Indian Men
Abate, N., Chandalia, M., Snell, P. G., & Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031843 · Cited by 201
Hunter, S. J., & Garvey, W. T. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00300-3 · Cited by 200
Leptin: in search of role(s) in human physiology and pathophysiology
Mantzoros, C. S., & Moschos, S. J. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00571.x · Cited by 198
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.
Lehto, M. J., Tuomi, T., Mahtani, M. M., Widén, E., Forsblom, C. M., Sarelin, L., Gullström, M., Isomaa, B., Lehtovirta, M., Hyrkkö, A., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119199 · Cited by 198
Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction
Schenk, S., McCurdy, C. E., Philp, A., Chen, M. Z., Holliday, M. J., Bandyopadhyay, G. K., Osborn, O., Baar, K., & Olefsky, J. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58554 · Cited by 197
Uusitupa, M., Lindi, V., Louheranta, A., Salopuro, T., Lindström, J., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes · doi:10.2337/diabetes.52.10.2532 · Cited by 196
Knowler (2011) · doi:10.1001/archinternmed.2011.367 · Cited by 194
Self-citationHyperinsulinemia and bone mineral density in an elderly population: The Rotterdam study
Stolk, R. P., van Daele, P. L. A., Pols, H. A. P., Burger, H., Hofman, A., Birkenhäger, J. C., Lamberts, S. W. J., & Grobbee, D. E. (1996) · Bone · doi:10.1016/8756-3282(96)00079-8 · Cited by 194
Metadata
- Authors
- Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1993-12-30
- Volume
- 329
- Issue
- 27
- Pages
- 1988-1992
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2334309509
- Cited by
- 1,508
- References
- 27
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 30 · 2023: 22 · 2022: 34 · 2021: 38 · 2020: 39 · 2019: 37 · 2018: 40 · 2017: 30 · 2016: 40 · 2015: 52 · 2014: 44 · 2013: 45 · 2012: 44
- FWCI
- 30.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin resistance, type 2 diabetes, Pima Indians, obesity, acute insulin response, hepatic glucose production, insulin action, diabetes risk factors, hyperinsulinemic-euglycemic clamp, glucose tolerance
- MeSH terms
- Insulin Secretion, Adult, Arizona, Body Composition, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glucose, Glucose Tolerance Test, Humans, Indians, North American, Insulin, Insulin Resistance, Liver, Male, Obesity, Prospective Studies, Risk Factors, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review